A little over two years after Lyndra Therapeutics Inc. first unveiled its technology for time-delayed drug delivery through a simple pill, the company has raised $55 million to continue developing the technology for public consumption. By creating a new kind of ultra long-acting drug delivery mechanism in pills, the company claims it can remove the […]
View More Aiming to change the way people take medicine, Lyndra Therapeutics raises $55 millionCategory: schizophrenia
Revising the results of last year’s study, Posit Science still effectively combats dementia
Revising the results of their headline-grabbing, decade-long study, researchers from top universities still believe that a brain training exercise from app developer Posit Science can actually reduce the risk of dementia among older adults. The groundbreaking study still has incredible implications for the treatment of neurological disorders associated with aging — and helps to validate… Read More